UY30542A1 - Formulacion de aerosol para la inhalacion de agonistas beta - Google Patents

Formulacion de aerosol para la inhalacion de agonistas beta

Info

Publication number
UY30542A1
UY30542A1 UY30542A UY30542A UY30542A1 UY 30542 A1 UY30542 A1 UY 30542A1 UY 30542 A UY30542 A UY 30542A UY 30542 A UY30542 A UY 30542A UY 30542 A1 UY30542 A1 UY 30542A1
Authority
UY
Uruguay
Prior art keywords
inhalation
aerosol formulation
beta agonists
radicals
compounds
Prior art date
Application number
UY30542A
Other languages
English (en)
Inventor
Rainer Weitzel
Kirsten Radau
Michael Aven
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of UY30542A1 publication Critical patent/UY30542A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Abstract

La presente invencion se refiere a una formulacion de aerosol exenta de gas propulsor, que contiene uno o más compuestos de la formula general 1, en donde los radicales R1, R2, R3 y X- pueden tener los significados mencionados en las reivindicaciones y en la memoria descriptiva, y contiene otros dos principios activos, para la inhalacion.
UY30542A 2006-08-18 2007-08-15 Formulacion de aerosol para la inhalacion de agonistas beta UY30542A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06119131 2006-08-18
EP07101129 2007-01-25

Publications (1)

Publication Number Publication Date
UY30542A1 true UY30542A1 (es) 2008-03-31

Family

ID=38521160

Family Applications (1)

Application Number Title Priority Date Filing Date
UY30542A UY30542A1 (es) 2006-08-18 2007-08-15 Formulacion de aerosol para la inhalacion de agonistas beta

Country Status (18)

Country Link
US (2) US20080041369A1 (es)
EP (1) EP2054084A1 (es)
JP (1) JP2010501022A (es)
KR (1) KR20090057393A (es)
AR (1) AR062425A1 (es)
AU (1) AU2007285747A1 (es)
BR (1) BRPI0715761A2 (es)
CA (1) CA2660488A1 (es)
CO (1) CO6170341A2 (es)
IL (1) IL197025A0 (es)
MX (1) MX2009001759A (es)
NO (1) NO20090407L (es)
NZ (1) NZ575425A (es)
PE (1) PE20081319A1 (es)
SG (1) SG174058A1 (es)
TW (1) TW200817011A (es)
UY (1) UY30542A1 (es)
WO (1) WO2008020057A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056916B2 (en) * 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
US7220742B2 (en) * 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
US20050255050A1 (en) * 2004-05-14 2005-11-17 Boehringer Ingelheim International Gmbh Powder formulations for inhalation, comprising enantiomerically pure beta agonists
CN101208316B (zh) 2005-08-15 2012-05-09 贝林格尔·英格海姆国际有限公司 制备β-模拟物的方法
EP2675439A2 (en) 2011-02-17 2013-12-25 Cipla Limited Combination of glycopyrrolate and a beta2 -agonist
CN103781468A (zh) 2011-08-12 2014-05-07 勃林格殷格翰动物保健有限公司 治疗及预防猫科动物心脏衰竭的方法中所用的起搏电流(If)抑制剂
WO2014016548A2 (en) 2012-07-27 2014-01-30 Cipla Limited Pharmaceutical composition
CA2888428C (en) 2012-12-21 2021-07-13 Boehringer Ingelheim Vetmedica Gmbh Ciclesonide for the treatment of airway disease in horses
DK2934544T3 (en) * 2012-12-21 2019-03-04 Boehringer Ingelheim Vetmedica Gmbh PHARMACEUTICAL FORMULA INCLUDING CICLESONID
DK3157522T3 (da) 2014-06-18 2019-12-09 Boehringer Ingelheim Vetmedica Gmbh Muskarin-antagonister og kombinationer deraf til behandlingen af luftvejssygdomme i heste
US11701478B2 (en) 2015-10-09 2023-07-18 Boehringer Ingelheim International Gmbh Method for coating microstructured components
CN115209884A (zh) * 2020-01-20 2022-10-18 广州谷森制药有限公司 含有格隆溴铵和盐酸奥达特罗的可吸入制剂
US20210393521A1 (en) * 2020-06-23 2021-12-23 Cai Gu Huang Preparation of a pharmaceutical composition of olodaterol, tiotropium bromide and budesonide

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR890000664B1 (ko) * 1981-10-19 1989-03-22 바리 안소니 뉴우샘 미분된 베클로메타손 디프로피오네이트 일수화물의 제조방법
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
US6960597B2 (en) * 2000-06-30 2005-11-01 Orth-Mcneil Pharmaceutical, Inc. Aza-bridged-bicyclic amino acid derivatives as α4 integrin antagonists
DE10130371A1 (de) * 2001-06-23 2003-01-02 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
US20030018019A1 (en) * 2001-06-23 2003-01-23 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics
DE10253282A1 (de) * 2002-11-15 2004-05-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung
US7056916B2 (en) * 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
DE102004019540A1 (de) * 2004-04-22 2005-11-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen
US20050239778A1 (en) * 2004-04-22 2005-10-27 Boehringer Ingelheim International Gmbh Novel medicament combinations for the treatment of respiratory diseases
JP2007533683A (ja) * 2004-04-22 2007-11-22 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 呼吸器系疾患治療用のベンゾオキサジン含有医薬組成物
US7220742B2 (en) * 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
DE102004024454A1 (de) * 2004-05-14 2005-12-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Enantiomerenreine Betaagonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
JP2008510014A (ja) * 2004-08-16 2008-04-03 セラヴァンス， インコーポレーテッド β２アドレナリン作用性レセプターアゴニスト活性およびムスカリン性レセプターアンタゴニスト活性を有する化合物
TWI482772B (zh) * 2006-08-21 2015-05-01 Astrazeneca Ab 適合口服且包含三唑并[4,5-d]嘧啶衍生物之組合物

Also Published As

Publication number Publication date
JP2010501022A (ja) 2010-01-14
CA2660488A1 (en) 2008-02-21
WO2008020057A1 (de) 2008-02-21
NZ575425A (en) 2011-12-22
AR062425A1 (es) 2008-11-05
MX2009001759A (es) 2009-02-25
US20080041369A1 (en) 2008-02-21
AU2007285747A1 (en) 2008-02-21
KR20090057393A (ko) 2009-06-05
CO6170341A2 (es) 2010-06-18
IL197025A0 (en) 2009-11-18
PE20081319A1 (es) 2008-10-16
EP2054084A1 (de) 2009-05-06
NO20090407L (no) 2009-04-29
SG174058A1 (en) 2011-09-29
US20120058980A1 (en) 2012-03-08
BRPI0715761A2 (pt) 2013-09-24
TW200817011A (en) 2008-04-16

Similar Documents

Publication Publication Date Title
UY30542A1 (es) Formulacion de aerosol para la inhalacion de agonistas beta
ECSP088294A (es) Formulación en aerosol para la inhalación de beta-agonistas
ECSP20027480A (es) Indolil alquil amino derivados sustituidos como nuevos inhibidores de la histona desacetilasa
UY30543A1 (es) Formulacion de aerosol para la inhalacion de beta- agonistas
CR11618A (es) Inhibidores macrocíclicos de serina proteasa
CR11106A (es) Inhibidores de cinasa p710 s6
CO6270311A2 (es) Derivados bis-(sulfonilamino) en terapia 066
CO6160235A2 (es) Isoxazolinas insecticidas
ECSP10010272A (es) Derivados bis-(sulfonilamino) para uso en terapia
CR7956A (es) Oxazolidinonas de indolona antibacterial intermedios para su preparacion y composiciones farmaceuticas que contienen los mismos
CR8986A (es) Isoxazoles sustituidos como fungicidas
UY31468A1 (es) Derivados bis-(sulfonilamino) en terapia 065
ECSP066751A (es) Piperidinilcarbonil-pirrolidinas y su uso como agonistas de melanocortina
UY30610A1 (es) Moduladores de mglur5
HN2008000088A (es) Heterociclicos de 1,4-dihidropiridina- fusionada, procesos para preparar los mismos, su uso y las composiciones que los contienen.
ECSP067004A (es) Formulación en aerosol para la inhalación de beta-agonistas
ECSP088252A (es) 7-aza-indazoles sustituidos, composiciones que los contienen, procedimiento de fabricación y utilización
CR8205A (es) Derivados de nicotinamida utiles como inhibidores de pde4
CR9391A (es) Derivados de indanil-piperazinas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
UY29394A1 (es) Derivados sustituidos de n-(5-(2-propilamino.1.hidroxietil)-2-hdroxifenil) metano sulfonamida, composiciones farmacéuticas que lo contienen y aplicaciónes.
UY30356A1 (es) Derivados de 3-halo-n-(2.(4-fluorofenil)-4-oxobutil)-n-metil-5-(trifluorometil)benzamida y composiciones de los mismos.
UY32635A (es) Derivados de bis-(sulfonilamino) en terapia 735
UY30552A1 (es) Combinaciones farmacologiicas en base a derivados sustituidos de la n-(5-{2-[1,1-dimetil-propilamino]-1-hidroxi-metil}-2-hidroxi-fenil)-metansulfonamida y aplicaciones
HN2011000404A (es) Derivados de enfumafungina y composicion comprendiendo los mismos
UY30555A1 (es) Formulacion aerosol para la inhalacion de beta-agonistas

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20170725